Ledger.Open graph →
SEC Form D · filed March 17, 2022

PolyCore Therapeutics, Inc

Offering
$4.7M
Sold
$4.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Kelly Beck · Philadelphia, PAExec · Director · PromoterChristopher B. Cashman · Philadelphia, PADirectorFrederick Callori · Philadelphia, PADirectorChris Garabedian · Delanson, NYDirectorJames B. Harris · Philadelphia, PADirectorChristopher B. Cashman · Philadelphia, PADirectorKelly Beck · Philadelphia, PAExec · Director · PromoterFrederick Callori · Philadelphia, PADirectorChris Garabedian · Delanson, NYDirectorJames B. Harris · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗